Display Settings:

Format

Send to:

Choose Destination

    J Am Geriatr Soc. 2008 May;56(5):808-15. Epub 2008 Mar 21.

    Consensus list of signals to detect potential adverse drug reactions in nursing homes.

    Handler SM, Hanlon JT, Perera S, Roumani YF, Nace DA, Fridsma DB, Saul MI, Castle NG, Studenski SA.

    Division of Geriatric Medicine, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA. handler@pitt.edu

    OBJECTIVES: To develop a consensus list of agreed-upon laboratory, pharmacy, and Minimum Data Set signals that a computer system can use in the nursing home to detect potential adverse drug reactions (ADRs). DESIGN: Literature search for potential ADR signals, followed by an internet-based, a two-round, modified Delphi survey. SETTING: A nationally representative survey of experts in geriatrics. PARTICIPANTS: Panel of 13 physicians, 10 pharmacists, and 13 advanced practitioners. MEASUREMENTS: Mean score and 95% confidence interval (CI) for each of 80 signals rated on a 5-point Likert scale (5=strong agreement with likelihood of indicating potential ADRs). Consensus agreement indicated by a lower-limit 95% CI of 4.0 or greater. RESULTS: Panelists reached consensus agreement on 40 signals: 15 laboratory and medication combinations, 12 medication concentrations, 10 antidotes, and three Resident Assessment Protocols (RAPs). Highest consensus scores (4.6, 95% CI=4.4-4.9 or 4.4-4.8) were for naloxone when taking opioid analgesics; phytonadione when taking warfarin; dextrose, glucagon, or liquid glucose when taking hypoglycemic agents; medication-induced hypoglycemia; supratherapeutic international normalized ratio when taking warfarin; and triggering the Falls RAP when taking certain medications. CONCLUSION: A multidisciplinary expert panel was able to reach consensus agreement on a list of signals to detect potential ADRs in nursing home residents. The results of this study can be used to prioritize an initial list of signals to be included in paper- or computer-based methods for potential ADR detection.

    PMID: 18363678 [PubMed - indexed for MEDLINE]

    PMCID: 2695658

    Supplemental Content

    Click here to read Click here to read Click here to read Click here to read

    Patient drug information

    • Glucagon (GlucaGen Diagnostic Kit®)

      Glucagon is a hormone produced in the pancreas. Glucagon is used to raise very low blood sugar. Glucagon is also used in diagnostic testing of the stomach and other digestive organs.

    • Warfarin (Coumadin®)

      Warfarin is used to prevent blood clots from forming or growing larger in your blood and blood vessels. It is prescribed for people with certain types of irregular heartbeat, people with prosthetic (replacement or mechan...

    • Phytonadione (Mephyton®)

      Phytonadione (vitamin K) is used to prevent bleeding in people with blood clotting problems or too little vitamin K in the body. Phytonadione is in a class of medications called vitamins. It works by providing vitamin K ...